SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Thursday reported a loss of $10.8 million in its first quarter.
The Seattle-based company said it had a loss of 19 cents per share.
The biotechnology company posted revenue of $640,000 in the period.
In the final minutes of trading on Thursday, the company's shares hit 97 cents. A year ago, they were trading at $3.90.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTIC at https://www.zacks.com/ap/CTIC